News Banner

MaxQ News

Posts about Products news:

Fujifilm AI Platform in Clinical Use for ICH Detection and Diagnosis

Lexington, Mass., November 23, 2021 - FUJIFILM Healthcare Americas Corporation, a leading provider of diagnostic and enterprise imaging solutions, announced two of its customers are using the company’s REiLI Artificial Intelligence (AI) platform in clinical practice. Capital Health of Pennington, NJ is using this platform for a solution that automatically and rapidly identifies and prioritizes suspected Intracranial Hemorrhage (ICH) for potential stroke patients, and the University Radiology Group (URG) located throughout New Jersey is using the platform to support their accelerated detection and diagnosis of breast cancer.

“Fujifilm strategically developed REiLI as an open, vendor-neutral platform that manages workflow and delivers AI results through our Synapse 7x diagnostic applications,” said Bill Lacy, senior vice president, medical informatics, FUJIFILM Healthcare Americas Corporation. “This is the answer for Synapse customers as to how they can connect Fujifilm-developed, or in the case of Capital Health and URG, third-party algorithm results directly into their Synapse PACS diagnostic workflow in the most impactful ways to accelerate clinical decisions.”

The ACCIPIO® Suite of Clinical Artificial Intelligence Applications

MaxQ Dec 4, 2020 2:38:00 PM

MaxQ AI Partners with Fujifilm to Commercialize the ACCIPIO® Suite

Fujifilm enters multi-year global distribution agreement to deliver MaxQ’s ACCIPIO suite of clinical artificial intelligence applications through the FujiFilm Synapse PACS platform.

Tel Aviv, Israel – December 4th, 2020 – MaxQ AI, the industry-leading healthcare technology company that delivers comprehensive clinical workflow solutions assisting with improved patient triage and diagnosis, announced today –the multi-year partnership with FUJIFILM Medical Systems U.S.A., Inc., a leading provider of enterprise imaging solutions, to commercialize the Accipio Clinical Platform.

MaxQ AI leads AI security with ISO 27799 certification for health informatics

MaxQ Dec 2, 2020 5:45:00 PM

Information Security and ISO 27001 Recertification

New healthcare information security certification demonstrates commitment to the highest standards of data protection across the company’s operations, systems, and products.

Tel Aviv, Israel – December 2nd, 2020 – MaxQ AI, the industry-leading healthcare technology company that delivers comprehensive clinical workflow solutions assisting with improved patient triage and diagnosis, announced today that after undergoing stringent reviews by the British Standards Institution (BSI), it has achieved ISO 27799 certification and ISO 27001 recertification. Both certifications are widely recognized international standards for information security management systems. These standards separate MaxQ in its commitment to deploying the Accipio Clinical Platform as a comprehensive, seamless, and secure solution for the healthcare industry.

MaxQ AI to offer intracranial hemorrhage (ICH)

MaxQ Dec 4, 2019 6:03:00 PM

AI Software Applications on Blackford Platform

ACCIPIO® AI-powered tools assess non-contrast head CT images for intracranial hemorrhage prioritization and provide slice-level annotation

Edinburgh, UK & Tel Aviv, Israel – December 4, 2019 – Blackford, the centralized medical imaging platform, today announced that MaxQ AI’s CE Marked, TGA Approved Accipio Ix™ ICH solution for stroke and head trauma is now available on the Blackford Platform.

Developed by MaxQ AI, the ACCIPIO ICH and Stroke Platform with INSIGHT™ uses artificial intelligence in the assessment of non-contrast head CT images for suspected intracranial hemorrhage (ICH). Accipio Ix is intended for identification and prioritization, while Accipio Ax™ also includes slice-level annotation.

(ICH) Software to be Integrated on Philips’ Computed Tomography Systems

MaxQ Oct 15, 2019 10:41:00 AM

MaxQ AI Intracranial Hemorrhage (ICH)

MaxQ AI’s ACCIPIO® ICH and stroke software will be integrated on Philips Computed Tomography Systems.

Tel Aviv, Israel – October 15, 2019 MaxQ AI, the industry-leading medical diagnostic AI company, today announced that the company’s ACCIPIO® intracranial hemorrhage (ICH) and stroke software will be integrated on Philips’ computed tomography (CT) systems. The integration of ACCIPIO’s AI-powered solutions into Philips CT systems will support the detection of ICH to augment caregivers in identifying and prioritizing patients suffering from stroke, traumatic brain injury, head trauma, and other life-threatening conditions.

MaxQ AI Continues to Deploy Intelligence-Based Clinical Technology

MaxQ Nov 18, 2018 5:29:00 PM

MaxQ AI Continues to Deploy Intelligence-Based Clinical Decision Support Technology Across the Healthcare Industry

CHICAGO, IL – November 28, 2017 – Today, MaxQ AI announced its third industry engagement to bring MaxQ AI’s A.I.-based clinical decision support application to imaging experts working in hospital emergency rooms and other acute care settings.

MedyMatch Reveals Artificial Intelligence Deep Vision

MaxQ Nov 22, 2016 6:21:00 PM

Intracranial Bleed Detection Technology

Tel Aviv, Israel – November 22, 2016 – MedyMatch Technology Ltd., (“MedyMatch”) the deep learning and artificial intelligence company, announced today that after several years of extensive research and development, it has achieved a major milestone in the availability, for research, of an artificial intelligence-based technology that can help detect the presence of intracranial hemorrhage or brain bleed which can occur in cases of brain trauma and stroke. Subtle bleeds are difficult to detect and if misinterpreted or missed by a physician can lead to serious patient injury and even death.